Article
Visitors to the Marco booth #1311 at this year's American Society ofCataract and Refractive Surgery (ASCRS) annual meeting are witness to anew technology that makes it possible to reduce refraction time to as littleas 30 seconds.
Bausch + Lomb launches its enVista Aspire monofocal and toric IOLs in the European Union
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
4DMT refocuses pipeline to prioritize 4D-150 trials in wet AMD and DME
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Formycon partners with Teva, Klinge Biopharma for commercialization of aflibercept biosimilar FYB203 (AHZANTIVE)
Bausch + Lomb acquires Whitecap Biosciences